Sequential doxorubicin plus vinorelbine (AV) followed by docetaxel plus carboplatin (DC) as neoadjuvant chemotherapy for advanced breast cancer (BC)

被引：0
|
作者：
Santisteban, Marta
De la Cruz, Susana
Sola, Jesus Javier
Aramendia, Jose Manuel
Espinos, Jaime
Garran, Cristina
Martinez-Regueira, Fernando
Zornoza, Gerardo
Fernandez-Hidalgo, Oscar
Nieto, Yago
机构：
[1] Clin Univ Navarra, Clin Oncol, Pamplona, Spain
[2] Clin Univ Navarra, Breast Dis Unit, Pamplona, Spain
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：86 / 86
页数：1
相关论文
共 50 条
  • [31] SEQUENTIAL CHEMOTHERAPY WITH CISPLATIN PLUS VINORELBINE FOLLOWED BY WEEKLY DOCETAXEL IN LOCALLY ADVANCED OR METASTATIC NON SMALL-CELL LUNG CANCER: PRELIMINARY RESULTS
    Sperandi, Francesca
    Esposti, Claudia Degli
    Berselli, Annalisa
    Melotti, Barbara
    Martoni, Andrea A.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1272 - S1272
  • [32] Two special types of breast cancer presenting as progressive disease after neoadjuvant chemotherapy with docetaxel plus doxorubicin
    Takahashi T.
    Akashi-Tanaka S.
    Fukutomi T.
    Watanabe T.
    Katsumata N.
    Miyakawa K.
    Hasegawa T.
    Tsuda H.
    [J]. Breast Cancer, 2001, 8 (3) : 234 - 237
  • [33] A phase II trial of docetaxel plus carboplatin plus bevacizumab as neoadjuvant therapy for triple negative breast cancer
    Chacon Lopez-Muniz, J. I.
    Cardenas, J. D.
    Santos Rodriguez, A. K.
    Esteban Esteban, M. C.
    Munoz Platon, E.
    Rubio Salvador, A. R.
    Alonso Soler, S. E.
    Fernandez Franco, L.
    San Juan del Moral, A.
    Burgueno Lorenzo, I.
    Trujillo Alba, B. L.
    Martinez Moreno, E.
    Moya Gomez, P.
    Cruz Mora, M. A.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S283 - S283
  • [34] Neoadjuvant Doxorubicin followed sequentially by Cisplatin-Docetaxel in locally advanced breast cancer
    不详
    [J]. BREAST, 2005, 14 : S42 - S42
  • [35] Neoadjuvant chemotherapy plus radical surgery followed by chemotherapy in locally advanced cervical cancer
    Angioli, R.
    Luvero, D.
    Plotti, F.
    Zullo, M.
    Damiani, P.
    Angelucci, M.
    Ricciardi, R.
    Aloisi, A.
    Scaletta, G.
    Panici, P. Benedetti
    [J]. GYNECOLOGIC ONCOLOGY, 2012, 125 : S4 - S4
  • [36] Neoadjuvant chemotherapy plus radical surgery followed by chemotherapy in locally advanced cervical cancer
    Angloli, Roberto
    Plotti, Francesco
    Montera, Roberto
    Aloisi, Alessia
    Luvero, Daniela
    Capriglione, Stella
    Terranova, Corrado
    Nardone, Carlo De Cicco
    Muzii, Ludovico
    Benedetti-Panici, Pierluigi
    [J]. GYNECOLOGIC ONCOLOGY, 2012, 127 (02) : 290 - 296
  • [37] HER2 expression-based approach of neoadjuvant chemotherapy with doxorubicin plus cyclophosphamide or docetaxel plus cyclophosphamide for operable breast cancer
    Ishikawa, Takashi
    Shimizu, Daisuke
    Takeshi, Sasaki
    Tanabe, Mikiko
    Ota, Ikuko
    Kito, Ayako
    Nozawa, Akinori
    Kawachi, Kae
    Morita, Satoshi
    Chishima, Takashi
    Ichikawa, Yasushi
    [J]. CANCER RESEARCH, 2009, 69
  • [38] Neoadjuvant pembrolizumab plus decitabine followed by standard neoadjuvant chemotherapy for locally advanced HER2-breast cancer
    Bear, Harry Douglas
    Idowu, Michael O.
    Poklepovic, Andrew
    Sima, Adam
    Kmieciak, Maciej
    [J]. CANCER RESEARCH, 2020, 80 (04)
  • [39] Neoadjuvant regimen with epirubicin (E) plus cyclophpsphamide (C) followed by docetaxel (T) plus capecitabine (X) in locally advanced breast cancer (LABC)
    Saracchini, S.
    Boccalon, M.
    Ferlante, M.
    Manocchi, M.
    Rositani, P.
    Sul-faro, S.
    Marus, W.
    Michieli, E.
    Bonamini, M.
    Vaclaw, B.
    Arcicasa, M.
    Roncadin, M.
    Piazza, R.
    Antonimi, Canterin F.
    Tumolo, S.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : XI13 - XI13
  • [40] The Efficacy and Toxicity of Neoadjuvant Chemotherapy Regimens of Epirubicin Plus Cyclophosphamide Followed by Docetaxel or Paclitaxel in Female Breast Cancer Patients
    Wu, Xian
    Ye, Chaoran
    Wang, Xingmeng
    Cai, Ruyu
    Yang, Junzhe
    Yu, Xiafei
    Zhou, Yi
    Shen, Li
    Zhu, Yanhui
    Liu, Xiaoan
    [J]. CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 1517 - 1527
12345